10x Genomics (TXG) Free Cash Flow (2018 - 2026)
10x Genomics (TXG) free cash flow from Sep 30, 2018 to Mar 31, 2026. The TTM 10x Genomics (TXG) free cash flow is $122M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
10x Genomics (TXG) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +169.33% |
Annual Free Cash Flow change of 10x Genomics (TXG)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $25M | -81.15% |
| 2025 | $130M | -2370.68% |
| 2024 | -$5.73M | -91.02% |
| 2023 | -$64M | -61.40% |
| 2022 | -$165M | +34.75% |
| 2021 | -$123M | -51.82% |
| 2020 | -$255M | +3038.96% |
| 2019 | -$8.11M | -90.19% |
| 2018 | -$83M | +471.85% |
| 2017 | -$14M | N/A |